Skip to main content
Premium Trial:

Request an Annual Quote

Genedata Partners with EC-Backed Infections and Cancer Consortium

NEW YORK, June 27 (GenomeWeb News) - Genedata today announced a partnership with the Infections and Cancer (INCA) consortium, a European Commission-backed research program to discover the role of chronic infection in the development of cancer.

 

Genedata will provide research informatics to support the consortium's research. Financial details were not disclosed.

 

"INCA will help researchers develop new prevention measures and treatments against cancers such as leukemia, stomach cancer, and cervical cancer," Thomas Schulz, INCA's principal coordinator, said in a statement. The consortium will focus on five viruses and the Helicobacter pylori bacterium, Genedata said.

 

The four-year program kicked off in January and will receive €12.6 million ($15.9 million) of EC funding as part of Europe's Sixth Framework Life-Science-Health program. The consortium includes 30 research organizations from 13 European countries.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.